Posted at 10:26 a.m., Monday, March 5, 2007
Cyanotech shares lifted by European regulatory ok
Advertiser Staff
Shares of Kailua-Kona-based Cyanotech Corp. rose 9 percent to $1.76 a share as of 10 a.m. on the Nasdaq Capital Market exchange after the company said it obtained regulatory approval for BioAstin Natural Astaxanthin in the European Union.The approval allows the importation of BioAstin into all of the 27 member countries, Cyanotech said.
"Europe is the ideal market for BioAstin," said Cyanotech chief executive and founder, Gerald Cysewski.
Astaxanthin is a human and animal dietary supplement.
